Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodological hurdles in conducting pharmacoeconomic analyses.

J D Rizzo1, N R Powe

  • 1International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry, Medical College of Wisconsin, Milwaukee, USA.

Pharmacoeconomics
|October 28, 1999
PubMed
Summary

Pharmacoeconomic evaluations demonstrate the value of medical interventions, guiding decisions on new medications. Addressing methodological challenges ensures these studies provide essential insights for healthcare stakeholders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of haploidentical hematopoietic cell transplantation conditioning intensity on the incidence and severity of post-transplantation viral infections.

Bone marrow transplantation·2016
Same author

Salvage haploidentical hematopoietic cell transplantation for graft rejection following a prior haploidentical allograft.

Bone marrow transplantation·2016
Same author

Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN.

Bone marrow transplantation·2016
Same author

Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.

Bone marrow transplantation·2016
Same author

Survival of patients who develop solid tumors following hematopoietic stem cell transplantation.

Bone marrow transplantation·2015
Same author

Bortezomib-based induction for transplant ineligible AL amyloidosis and feasibility of later transplantation.

Bone marrow transplantation·2015

Area of Science:

  • Health Economics
  • Pharmaceutical Policy
  • Outcomes Research

Background:

  • Rising global healthcare expenditures necessitate research demonstrating the value of medical interventions.
  • Pharmacoeconomic evaluations are crucial tools for informed decision-making by various healthcare stakeholders.

Purpose of the Study:

  • To describe the applications of pharmacoeconomic trial results.
  • To identify and discuss study designs and methods for gathering nonclinical and patient-reported outcomes.
  • To highlight key methodological considerations for conducting robust pharmacoeconomic research.

Main Methods:

  • Review of pharmacoeconomic trial methodologies.
  • Discussion of data collection for nonclinical and patient experience outcomes.

Related Experiment Videos

  • Consideration of sample size, time horizons, and cost perspectives.

    • Main Results:

    • Pharmacoeconomic evaluations aid in assessing the value of pharmaceuticals.
    • Methodological challenges include gathering diverse outcome data and incorporating patient experience.
    • Standardized cost data collection and appropriate health-related quality-of-life (HR-QOL) instruments are important.

    Conclusions:

    • Well-designed pharmacoeconomic trials are essential for demonstrating treatment value.
    • Addressing methodological complexities is vital for the credibility and utility of these evaluations.
    • These studies justify their expense by informing critical healthcare decisions.